
P01008
ANT3_HUMANSERPINC1
Antithrombin-III
抗凝血酶-III
Homo sapiensTaxon: 9606
3D-structureBlood coagulationDirect protein sequencingDisease variantDisulfide bondGlycoproteinHemostasisHeparin-bindingPhosphoproteinProtease inhibitorProteomics identificationReference proteome+4
서열 길이
464
아미노산
분자량
52.6 kDa
이론값
실험 구조
27
PDB 항목
관련 질환
1
기록됨
기능 설명
Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade (PubMed:15140129, PubMed:15853774). AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa (PubMed:15140129). Its inhibitory activity is greatly enhanced in the presence of heparin
血浆中最重要的丝氨酸蛋白酶抑制剂,可调节凝血级联 (PubMed:15140129、PubMed:15853774)。 AT-III 抑制凝血酶、matriptase-3/TMPRSS7 以及因子 IXa、Xa 和 XIa (PubMed:15140129)。 在肝素存在下其抑制活性大大增强
您所阅读的中文介绍为AI翻译机制自动翻译,并未经过人工审核,如有错漏,请以英文原文为准!
국재 및 분포
조직 특이성
Found in plasma
관련 질환
Antithrombin III deficiency
An important risk factor for hereditary thrombophilia, a hemostatic disorder characterized by a tendency to recurrent thrombosis. Antithrombin-III deficiency is classified into 4 types. Type I: characterized by a 50% decrease in antigenic and functional levels. Type II: has defects affecting the thrombin-binding domain. Type III: alteration of the heparin-binding domain. Plasma AT-III antigen levels are normal in type II and III. Type IV: consists of miscellaneous group of unclassifiable mutations.
아미노산 서열
MYSNVIGTVTSGKRKVYLLSLLLIGFWDCVTCHGSPVDICTAKPRDIPMNPMCIYRSPEK KATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFA MTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFG DKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAIN
FASTA 형식 · 464 아미노산 · 분자량 52.6 kDa
실험 구조
27 PDB 항목1ANT1ATH1AZX1BR81DZG1DZH1E031E041E051JVQ1LK61NQ91OYH1R1L1SR51T1F1TB62ANT2B4X2B5T2BEH2GD42HIJ2ZNH3EVJ3KCG4EB1
번역 후 수식
- •Phosphorylated by FAM20C in the extracellular medium